论文部分内容阅读
摘要目的检测治疗早期正常脑血容量(nCBV)偏度及峰度变化对鉴别初诊为胶质母细胞瘤病人的早期肿瘤进展与假性进展的预测价值。材料与方法本回顾性研究经伦理委员会批准。本研究对135例初诊为胶质母细胞瘤且术后同时接受化疗和放疗(CCRT)的病人进行评估。
Abstract Objective To evaluate the predictive value of early normobaric cerebral blood volume (nCBV) skewness and kurtosis in the differential diagnosis of early tumor progression and pseudo-progression in patients with newly diagnosed glioblastoma. Materials and Methods This retrospective study was approved by the Ethics Committee. This study evaluated 135 patients with newly diagnosed glioblastoma who underwent concurrent chemotherapy and radiotherapy (CCRT) after surgery.